GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Shiller PE Ratio

Theralase Technologies (Theralase Technologies) Shiller PE Ratio : (As of May. 18, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Theralase Technologies Shiller PE Ratio Historical Data

The historical data trend for Theralase Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Shiller PE Ratio Chart

Theralase Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Theralase Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Theralase Technologies's Shiller PE Ratio

For the Medical Devices subindustry, Theralase Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theralase Technologies's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Shiller PE Ratio falls into.



Theralase Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Theralase Technologies's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Theralase Technologies's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.004/125.0724*125.0724
=-0.004

Current CPI (Dec. 2023) = 125.0724.

Theralase Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 -0.008 96.945 -0.010
201403 -0.009 98.604 -0.011
201406 -0.009 99.473 -0.011
201409 -0.009 99.394 -0.011
201412 -0.004 98.367 -0.005
201503 -0.010 99.789 -0.013
201506 -0.016 100.500 -0.020
201509 -0.016 100.421 -0.020
201512 -0.007 99.947 -0.009
201603 -0.009 101.054 -0.011
201606 -0.008 102.002 -0.010
201609 -0.011 101.765 -0.014
201612 -0.006 101.449 -0.007
201703 -0.010 102.634 -0.012
201706 -0.008 103.029 -0.010
201709 -0.011 103.345 -0.013
201712 -0.007 103.345 -0.008
201803 -0.006 105.004 -0.007
201806 -0.008 105.557 -0.009
201809 -0.005 105.636 -0.006
201812 -0.004 105.399 -0.005
201903 -0.006 106.979 -0.007
201906 -0.008 107.690 -0.009
201909 -0.008 107.611 -0.009
201912 -0.016 107.769 -0.019
202003 -0.037 107.927 -0.043
202006 -0.006 108.401 -0.007
202009 -0.008 108.164 -0.009
202012 -0.005 108.559 -0.006
202103 -0.003 110.298 -0.003
202106 -0.005 111.720 -0.006
202109 -0.004 112.905 -0.004
202112 -0.005 113.774 -0.005
202203 -0.006 117.646 -0.006
202206 -0.005 120.806 -0.005
202209 -0.004 120.648 -0.004
202212 -0.003 120.964 -0.003
202303 -0.005 122.702 -0.005
202309 -0.004 125.230 -0.004
202312 -0.004 125.072 -0.004

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Theralase Technologies  (OTCPK:TLTFF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Theralase Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Theralase Technologies (Theralase Technologies) Business Description

Traded in Other Exchanges
Address
41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Theralase Technologies (Theralase Technologies) Headlines